JP2025510096A5 - - Google Patents
Info
- Publication number
- JP2025510096A5 JP2025510096A5 JP2024556375A JP2024556375A JP2025510096A5 JP 2025510096 A5 JP2025510096 A5 JP 2025510096A5 JP 2024556375 A JP2024556375 A JP 2024556375A JP 2024556375 A JP2024556375 A JP 2024556375A JP 2025510096 A5 JP2025510096 A5 JP 2025510096A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- pharmaceutical composition
- composition according
- amb
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263321965P | 2022-03-21 | 2022-03-21 | |
| US63/321,965 | 2022-03-21 | ||
| PCT/US2023/015762 WO2023183297A1 (en) | 2022-03-21 | 2023-03-21 | Ion channel prosthetic compositions comprising lipid-coated crystals of amphotericin b |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510096A JP2025510096A (ja) | 2025-04-14 |
| JP2025510096A5 true JP2025510096A5 (enExample) | 2026-03-26 |
Family
ID=88101847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556375A Pending JP2025510096A (ja) | 2022-03-21 | 2023-03-21 | アムホテリシンｂの脂質被覆結晶を含むイオンチャネル補欠組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12419899B2 (enExample) |
| EP (1) | EP4496588A4 (enExample) |
| JP (1) | JP2025510096A (enExample) |
| KR (1) | KR20240164801A (enExample) |
| CN (1) | CN119365218A (enExample) |
| AU (1) | AU2023238751A1 (enExample) |
| CA (1) | CA3250825A1 (enExample) |
| CL (1) | CL2024002812A1 (enExample) |
| CO (1) | CO2024013912A2 (enExample) |
| IL (1) | IL315719A (enExample) |
| MX (1) | MX2024011449A (enExample) |
| WO (1) | WO2023183297A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL315719A (en) | 2022-03-21 | 2024-11-01 | Univ Illinois | Prosthetic assemblies of ion channels containing lipid-coated amphotericin B crystals |
| EP4780466A1 (en) * | 2023-09-20 | 2026-07-29 | The Board Of Trustees Of The University Of Illinois | Additive effects for molecular prosthetcs and cftr modulators in cf epithelia |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE60901B1 (en) | 1986-08-21 | 1994-08-24 | Vestar Inc | Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
| US6406713B1 (en) | 1987-03-05 | 2002-06-18 | The Liposome Company, Inc. | Methods of preparing low-toxicity drug-lipid complexes |
| AU598958B2 (en) | 1987-11-12 | 1990-07-05 | Vestar, Inc. | Improved amphotericin b liposome preparation |
| US4906476A (en) | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
| CA2194049A1 (en) | 1994-06-28 | 1996-01-11 | Georgi Stankov | Novel clinical uses of polyene macrolides |
| US6323191B1 (en) | 1998-06-19 | 2001-11-27 | Genzyme Corporation | Small molecule chloride transport |
| AUPQ066399A0 (en) | 1999-05-31 | 1999-06-24 | Fujisawa Pharmaceutical Co., Ltd. | Antifungal combination use |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| AU2003304204B2 (en) | 2002-10-29 | 2009-12-24 | Insmed Incorporated | Sustained release of antiinfectives |
| US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
| HUP0500846A3 (en) | 2002-12-31 | 2008-10-28 | Nektar Therapeutics | Pharmaceutical formulation with an insoluble active agent for pulmonary administration |
| CA2511555A1 (en) | 2002-12-31 | 2004-07-22 | Nektar Therapeutics | Aerosolizable pharmaceutical formulation for fungal infection therapy |
| EP1631669A2 (en) | 2003-04-09 | 2006-03-08 | Biodelivery Sciences International, Inc. | Cochleate compositions directed against expression of proteins |
| TWI249408B (en) | 2003-12-10 | 2006-02-21 | Ind Tech Res Inst | New antifungal formulation and manufacturing method thereof |
| US7452524B2 (en) | 2004-01-27 | 2008-11-18 | Gilead Sciences, Inc. | Method for improvement of tolerance for therapeutically effective agents delivered by inhalation |
| WO2005120497A2 (en) | 2004-06-04 | 2005-12-22 | The Regents Of The University Of California | Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| CN101014322A (zh) | 2004-06-11 | 2007-08-08 | 吉藤德拉·纳提·维玛 | 盐水中富含固醇的添加两性霉素的混合层状脂质体及其制备方法 |
| ES2798263T3 (es) * | 2005-12-08 | 2020-12-10 | Insmed Inc | Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares |
| CN104825397A (zh) | 2006-04-03 | 2015-08-12 | 伊萨·奥迪迪 | 含有机溶胶涂层的受控释放递送物件 |
| HUE031951T2 (en) | 2006-10-10 | 2017-08-28 | Jina Pharmaceuticals Inc | Aqueous systems for lipid-based drug compounds; preparations, processes and their use |
| WO2009006311A2 (en) * | 2007-06-29 | 2009-01-08 | Wisconsin Alumni Research Foundation | Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals |
| CN101485629B (zh) * | 2008-01-16 | 2013-01-23 | 沈阳药科大学 | 一种给药系统及其制备方法 |
| BRPI1003990B1 (pt) | 2009-10-16 | 2021-09-14 | Lifecare Innovations Pvt. Ltd | Formulação para o tratamento de infecções fúngicas |
| US8507441B2 (en) | 2009-10-22 | 2013-08-13 | University of Pittsburgh—Of the Commonwealth Systems of Higher Education | Use of endostatin peptides for the treatment of fibrosis |
| US8945605B2 (en) | 2011-06-07 | 2015-02-03 | Parion Sciences, Inc. | Aerosol delivery systems, compositions and methods |
| RU2659729C2 (ru) * | 2012-07-30 | 2018-07-03 | Матинас Биофарма Нанотекнолоджис, Инк. | Кохлеаты, полученные с использованием фосфатидилсерина сои |
| KR102548341B1 (ko) | 2013-10-07 | 2023-06-26 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 개선된 치료 지수를 갖는 암포테리신 b 유도체 |
| JP6796581B2 (ja) | 2014-11-04 | 2020-12-09 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ | ミッシングタンパク質の小分子模倣体を用いた生理機能の回復 |
| ES2983639T3 (es) | 2016-04-08 | 2024-10-24 | The Board Of Trustees Of The Univ Illinois | Restauración mediada por moléculas pequeñas de la fisiología de la superficie de las vías respiratorias en epitelios pulmonares humanos de fibrosis quística |
| US10960018B2 (en) | 2016-04-15 | 2021-03-30 | The Uab Research Foundation | Methods and compounds for stimulating read-through of premature termination codons |
| PT3694526T (pt) * | 2017-10-11 | 2025-01-20 | Univ Illinois | Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas |
| IL315719A (en) | 2022-03-21 | 2024-11-01 | Univ Illinois | Prosthetic assemblies of ion channels containing lipid-coated amphotericin B crystals |
-
2023
- 2023-03-21 IL IL315719A patent/IL315719A/en unknown
- 2023-03-21 JP JP2024556375A patent/JP2025510096A/ja active Pending
- 2023-03-21 WO PCT/US2023/015762 patent/WO2023183297A1/en not_active Ceased
- 2023-03-21 KR KR1020247034896A patent/KR20240164801A/ko active Pending
- 2023-03-21 AU AU2023238751A patent/AU2023238751A1/en active Pending
- 2023-03-21 EP EP23775542.6A patent/EP4496588A4/en active Pending
- 2023-03-21 CA CA3250825A patent/CA3250825A1/en active Pending
- 2023-03-21 CN CN202380041480.3A patent/CN119365218A/zh active Pending
-
2024
- 2024-09-17 CL CL2024002812A patent/CL2024002812A1/es unknown
- 2024-09-18 MX MX2024011449A patent/MX2024011449A/es unknown
- 2024-09-20 US US18/891,739 patent/US12419899B2/en active Active
- 2024-10-16 CO CONC2024/0013912A patent/CO2024013912A2/es unknown
-
2025
- 2025-09-04 US US19/318,694 patent/US20260199383A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8461211B2 (en) | Use for budesonide and formoterol | |
| JP3342484B2 (ja) | 新規な配合 | |
| JPH03167120A (ja) | 呼吸疾患治療薬 | |
| JP2000502365A (ja) | 新規な組み合わせ | |
| RU2001119990A (ru) | Применение антагониста AT-1 или модулятора рецептора АТ-2 для лечения болезней, связанных с увеличением содержания рецепторов АТ-1 или АТ-2 | |
| JP2011173929A (ja) | 呼吸器官の細菌性疾患の処置 | |
| CN116492317A (zh) | 一种可吸入脂质纳米颗粒及其制备方法和应用 | |
| CN110300588A (zh) | 可吸入尼古丁调配物及其制造和使用方法 | |
| JP2003527412A (ja) | 安定化された乾燥粉末製剤 | |
| JP2025122121A (ja) | 肺線維症を処置するための方法及び組成物 | |
| CN1972730A (zh) | 格隆溴铵用于治疗儿童哮喘 | |
| CN116546980A (zh) | 用于肺部递送的药物组合物 | |
| JP2025510096A (ja) | アムホテリシンｂの脂質被覆結晶を含むイオンチャネル補欠組成物 | |
| JP2023538125A5 (enExample) | ||
| JP2009510142A (ja) | 急性および慢性肺障害の処置のための可溶性グアニル酸シクラーゼ活性化剤の使用 | |
| KR102259824B1 (ko) | 보센탄을 함유한 약학 제제 | |
| EP1086697A2 (en) | New combination of formoterol and budesonide | |
| JP2021176903A5 (enExample) | ||
| KR20260041516A (ko) | 닌테다닙을 함유하는 건조 분말 흡입 제제 및 그 제조방법 | |
| WO2017022814A1 (ja) | ネブライザー用組成物 | |
| CN120789080A (zh) | 一种用于慢性阻塞性肺疾病的治疗药物 | |
| HK40096956A (en) | Method and composition for treating pulmonary fibrosis | |
| KR20070110418A (ko) | 입자 및 그 입자를 함유하는 제제 | |
| Hindle et al. | Lung Surfactant Excipient Enhanced Growth Aerosol Formulations | |
| EP1915159A1 (en) | Use of megestrol acetate for the treatment of obstructive pulmonary diseases |